<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
 <result pre="(WHO) declaration of COVID-19 as a global pandemic. The severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) has been declared a"/>
 <result pre="declaration of COVID-19 as a global pandemic. The severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) has been declared a pandemic"/>
 <result pre="of COVID-19 as a global pandemic. The severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) has been declared a pandemic and"/>
 <result pre="has been clearly demonstrated for patients severely affected by the" exact="disease" post="caused by SARS-CoV-2, named COVID-19. Rheumatologists and clinicians world"/>
 <result pre="their patients from this infection. We know that patients with" exact="rheumatic" post="and musculoskeletal diseases (RMDs), particularly those with systemic autoimmune"/>
 <result pre="from this infection. We know that patients with rheumatic and" exact="musculoskeletal diseases" post="(RMDs), particularly those with systemic autoimmune diseases, are at"/>
 <result pre="patients with rheumatic and musculoskeletal diseases (RMDs), particularly those with" exact="systemic" post="autoimmune diseases, are at increased risk of infections due"/>
 <result pre="with rheumatic and musculoskeletal diseases (RMDs), particularly those with systemic" exact="autoimmune diseases," post="are at increased risk of infections due to the"/>
 <result pre="those with systemic autoimmune diseases, are at increased risk of" exact="infections" post="due to the RMD itself and due to immunosuppressive"/>
 <result pre="including corticosteroids and conventional synthetic, biologic, biosimilar and targeted synthetic" exact="disease" post="modifying antirheumatic drugs (DMARDs). At present, however, there is"/>
 <result pre="should continue their current RMD therapy, because a flare in" exact="disease" post="activity may follow discontinuation of therapy. Such flares may"/>
 <result pre="promise for the therapy of a severe COVID-19 cytokine release" exact="syndrome" post="[8]. Additional information is needed in order to fully"/>
 <result pre="to the significant burden of non-communicable diseases in LMIC, including" exact="cardiovascular" post="illness, diabetes and lung disease, combined with the highest"/>
 <result pre="significant burden of non-communicable diseases in LMIC, including cardiovascular illness," exact="diabetes" post="and lung disease, combined with the highest global prevalence"/>
 <result pre="of non-communicable diseases in LMIC, including cardiovascular illness, diabetes and" exact="lung disease," post="combined with the highest global prevalence of infections such"/>
 <result pre="and lung disease, combined with the highest global prevalence of" exact="infections" post="such as malaria, dengue, tuberculosis (TB) and HIV [10,"/>
 <result pre="the highest global prevalence of infections such as malaria, dengue," exact="tuberculosis" post="(TB) and HIV [10, 11]. Studies demonstrate that HIV-infected"/>
 <result pre="with low CD4 counts are at greater risk for influenza" exact="infection" post="and its complications including pneumococcal co-infection, longer hospital stays"/>
 <result pre="longer hospital stays and increased mortality, as well as prolonged" exact="viral" post="shedding [12â€&quot;14]. Persons with pulmonary TB (PTB) are at"/>
 <result pre="mortality, as well as prolonged viral shedding [12â€&quot;14]. Persons with" exact="pulmonary" post="TB (PTB) are at increased risk of influenza-associated mortality"/>
 <result pre="used by HIV positive patients may be protective from COVID-19" exact="infection" post="or serious complications, and there is interest in using"/>
 <result pre="and the follow-up is ambulatory [18]. The brunt of most" exact="acute" post="and chronic diseases is borne by the poor, and"/>
 <result pre="follow-up is ambulatory [18]. The brunt of most acute and" exact="chronic" post="diseases is borne by the poor, and it is"/>
 <result pre="nurses and medical staff and SARS-CoV-2Â infected patients all favour" exact="viral" post="spread. Political disruption and poor education with lack of"/>
 <result pre="Currently, the day to day running of clinic services for" exact="chronic" post="conditions including rheumatology outpatient clinics has stopped, jeopardizing new"/>
 <result pre="date. In addition, both HCQ and CQ are now in" exact="short" post="supply for patients taking it for RMD indications, as"/>
 <result pre="We have seen how the recent Ebola epidemic greatly undermined" exact="malaria" post="control efforts, resulting in an estimated 1 million malaria"/>
 <result pre="undermined malaria control efforts, resulting in an estimated 1 million" exact="malaria" post="cases seen in West Africa in 2014 [22]. Similarly,"/>
 <result pre="due to TB significantly increased [23]. In Latin America, COVID-19" exact="infection" post="is an additional challenge for the health systems and"/>
 <result pre="severely affected by the virus as their Northern high and" exact="upper" post="middle-income counterparts. Because of limited testing, a consequence of"/>
 <result pre="as their Northern high and upper middle-income counterparts. Because of" exact="limited" post="testing, a consequence of resource constraints, the actual number"/>
 <result pre="reported. However, even LMIC countries with more than 1000 confirmed" exact="infections" post="have not yet reported the massive mortalities seen in"/>
 <result pre="SARS-CoV-2 [27, 28]. Polymorphisms in the ACE gene, associated with" exact="essential hypertension," post="are described in Africa and South America [29, 30]."/>
 <result pre="patient management, were designed and implemented in a scenario of" exact="limited" post="resources. The protocols and previous experience with infectious diseases"/>
 <result pre="scenario of limited resources. The protocols and previous experience with" exact="infectious diseases" post="may be useful in this challenging situation [32]. Another"/>
 <result pre="and often thrived through many challenges, including the ravages of" exact="infectious" post="epidemics and the raw face of resource constraints. Rather"/>
 <result pre="infrastructure, connectivity and equipment for learners and educators, frequently in" exact="short" post="supply in LMIC. This should be seen as an"/>
 <result pre="ethical standards Disclosures None. References References 1.World Health Organisation. Coronavirus" exact="disease" post="Pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 2.Dâ€™Antiga L (2020) Coronaviruses and immunosuppressed"/>
 <result pre="during the third epidemic. Liver Transpl Mar 20. 10.1002/lt.25756 3.VeneritoVincenzoLopalcoGiuseppeIannoneFlorenzoCOVID-19," exact="rheumatic" post="diseases and immunosuppressive drugs: an appeal for medication adherenceRheumatology"/>
 <result pre="drugs: an appeal for medication adherenceRheumatology International202040582782810.1007/s00296-020-04566-932232551 4.FavalliEnnio GiulioIngegnoliFrancescaDe LuciaOrazioCincinelliGilbertoCimazRolandoCaporaliRobertoCOVID-19" exact="infection" post="and rheumatoid arthritis: Faraway, so close!Autoimmunity Reviews202019510252310.1016/j.autrev.2020.10252332205186 5.Yao X,"/>
 <result pre="optimized dosing design of hydroxychloroquine for the treatment of severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 10.1093/cid/ciaa237"/>
 <result pre="dosing design of hydroxychloroquine for the treatment of severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 10.1093/cid/ciaa237 6.Yazdany"/>
 <result pre="design of hydroxychloroquine for the treatment of severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 10.1093/cid/ciaa237 6.Yazdany J,"/>
 <result pre="regional, and national incidence and mortality for HIV, tuberculosis, and" exact="malaria" post="during 1990â€&quot;2013: a systematic analysis for the Global Burden"/>
 <result pre="during 1990â€&quot;2013: a systematic analysis for the Global Burden of" exact="Disease" post="Study 2013Lancet201438499471005107010.1016/S0140-6736(14)60844-825059949 12.CohenCMoyesJTempiaSGroomMWalazaSPretoriusMet al.Severe influenza-associated respiratory infection in high"/>
 <result pre="the Global Burden of Disease Study 2013Lancet201438499471005107010.1016/S0140-6736(14)60844-825059949 12.CohenCMoyesJTempiaSGroomMWalazaSPretoriusMet al.Severe influenza-associated" exact="respiratory" post="infection in high HIV prevalence setting, South Africa, 2009â€&quot;2011Emerg"/>
 <result pre="Global Burden of Disease Study 2013Lancet201438499471005107010.1016/S0140-6736(14)60844-825059949 12.CohenCMoyesJTempiaSGroomMWalazaSPretoriusMet al.Severe influenza-associated respiratory" exact="infection" post="in high HIV prevalence setting, South Africa, 2009â€&quot;2011Emerg Infect"/>
 <result pre="setting, South Africa, 2009â€&quot;2011Emerg Infect Dis201319111766177410.3201/eid1911.13054624209781 13.LinJCNicholKLExcess mortality due to" exact="pneumonia" post="or influenza during influenza seasons among persons with acquired"/>
 <result pre="to pneumonia or influenza during influenza seasons among persons with" exact="acquired" post="immunodeficiency syndromeArch Intern Med2001161344144610.1001/archinte.161.3.44111176770 14.von MollendorfCHellfersceeOValley-OmarZTreurnichtFKWalazaSMartinsonNAet al.Influenza viral shedding"/>
 <result pre="pneumonia or influenza during influenza seasons among persons with acquired" exact="immunodeficiency" post="syndromeArch Intern Med2001161344144610.1001/archinte.161.3.44111176770 14.von MollendorfCHellfersceeOValley-OmarZTreurnichtFKWalazaSMartinsonNAet al.Influenza viral shedding in"/>
 <result pre="persons with acquired immunodeficiency syndromeArch Intern Med2001161344144610.1001/archinte.161.3.44111176770 14.von MollendorfCHellfersceeOValley-OmarZTreurnichtFKWalazaSMartinsonNAet al.Influenza" exact="viral" post="shedding in a prospective cohort of HIV-infected and uninfected"/>
 <result pre="Infect Dis201821881228123710.1093/infdis/jiy31029800425 15.WalazaSCohenCNanooACohenALMcAnerneyJvon MollendorfCet al.Excess mortality associated with influenza among" exact="tuberculosis" post="deaths in South Africa, 1999â€&quot;2009PLoS One2015106e012917310.1371/journal.pone.012917326076197 16.Joob B, Wiwanitkit"/>
 <result pre="regions during the COVID-19 pandemic. Lancet 395(10230):1094â€&quot;1096 23.ZurcherKZwahlenMBallifMRiederHLEggerMFennerLInfluenza pandemics and" exact="tuberculosis" post="mortality in 1889 and 1918: analysis of historical data"/>
 <result pre="of historical data from SwitzerlandPLoS One.20161110e016257510.1371/journal.pone.016257527706149 24.Cardona-OspinaJAVillamil-GomezWEJimenez-CanizalesCECastaneda-HernandezDMRodriguez-MoralesAJEstimating the burden of" exact="disease" post="and the economic cost attributable to chikungunya, Colombia, 2014Trans"/>
 <result pre="Trop Med Hyg20151091279380210.1093/trstmh/trv09426626342 25.World Health Organisation. Report of the WHO-China" exact="Joint" post="Mission on Coronavirus Disease 2019. https://publicintelligence.net/who-china-mission-covid-19/. Accessed 6 April"/>
 <result pre="Health Organisation. Report of the WHO-China Joint Mission on Coronavirus" exact="Disease" post="2019. https://publicintelligence.net/who-china-mission-covid-19/. Accessed 6 April 2020 26.United Nations. World"/>
 <result pre="Za Zhi2020480E01232189489 29.MengeshaHGPetruckaPSpenceCTafesseTBEffects of angiotensin converting enzyme gene polymorphism on" exact="hypertension" post="in Africa: a meta-analysis and systematic reviewPLoS One.2019142e021105410.1371/journal.pone.021105430763326 30.PinheiroDSSantosRSJardimPSilvaEGReisAASPedrinoGRet"/>
 <result pre="al.The combination of ACE I/D and ACE2 G8790A polymorphisms revels" exact="susceptibility to" post="hypertension: a genetic association study in Brazilian patientsPLoS One2019148e022124810.1371/journal.pone.022124831430320"/>
 <result pre="polymorphisms revels susceptibility to hypertension: a genetic association study in" exact="Brazilian" post="patientsPLoS One2019148e022124810.1371/journal.pone.022124831430320 31.CaoYLiLFengZWanSHuangPSunXet al.Comparative genetic analysis of the novel"/>
</results>
